Schedule 13G ownership disclosure

SUNESIS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 867328502

Event date: 2019-01-23

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
12.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-19-016025
Form type
SC 13G/A
Filer
Aisling Capital IV, LP
CIK
CIK 1652910
Filed
Jan 24, 2019
Reporting period
Jan 23, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub